These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1425 related articles for article (PubMed ID: 12881481)
21. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Miura S; Matsuo Y; Saku K Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712 [TBL] [Abstract][Full Text] [Related]
22. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. Michaud SE; Dussault S; Groleau J; Haddad P; Rivard A J Mol Cell Cardiol; 2006 Aug; 41(2):275-84. PubMed ID: 16806264 [TBL] [Abstract][Full Text] [Related]
23. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897 [TBL] [Abstract][Full Text] [Related]
25. [Transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor induces an angiogenic phenotype in human cultured coronary endothelial cells]. Miura S; Fujino M; Tanigawa H; Matsuo Y; Saku K Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):104P-105P. PubMed ID: 12491796 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Otani A; Takagi H; Oh H; Suzuma K; Matsumura M; Ikeda E; Honda Y Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1192-9. PubMed ID: 10752960 [TBL] [Abstract][Full Text] [Related]
27. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748 [TBL] [Abstract][Full Text] [Related]
28. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). Chen WS; Kitson RP; Goldfarb RH In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin II and retinal pericytes migration. Nadal JA; Scicli GM; Carbini LA; Nussbaum JJ; Scicli AG Biochem Biophys Res Commun; 1999 Dec; 266(2):382-5. PubMed ID: 10600512 [TBL] [Abstract][Full Text] [Related]
31. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Kroll J; Waltenberger J Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473 [TBL] [Abstract][Full Text] [Related]
32. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725 [TBL] [Abstract][Full Text] [Related]
33. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Tayeh MA; Scicli AG Proc Assoc Am Physicians; 1998; 110(5):412-21. PubMed ID: 9756092 [TBL] [Abstract][Full Text] [Related]
35. Identification of angiotensin II type 2 (AT2) receptor domains mediating high-affinity CGP 42112A binding and receptor activation. Hines J; Heerding JN; Fluharty SJ; Yee DK J Pharmacol Exp Ther; 2001 Aug; 298(2):665-73. PubMed ID: 11454929 [TBL] [Abstract][Full Text] [Related]
36. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. Waltenberger J; Mayr U; Frank H; Hombach V J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939 [TBL] [Abstract][Full Text] [Related]
37. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function. Shiota M; Kusakabe H; Izumi Y; Hikita Y; Nakao T; Funae Y; Miura K; Iwao H Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):491-7. PubMed ID: 20018937 [TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240 [TBL] [Abstract][Full Text] [Related]
39. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells. Zhao X; Li X; Trusa S; Olson SC Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]